(Q59273802)
Statements
Natalizumab treatment reduces endothelial activity in MS patients (English)
Alban Millonig
Harald Hegen
Franziska Di Pauli
Rainer Ehling
Claudia Gneiss
Martina Hoelzl
Bettina Künz
Andreas Lutterotti
Dagmar Rudzki
Thomas Berger
Florian Deisenhammer